German pharmaceutical company Bayer and Yunona Holdings, representing the Ural Pharmaceutical Cluster (UPC) of Russia have entered a memorandum of understanding to manufacture drugs in Russia. The companies intend to establish themselves in the fields of production, marketing and distribution of pharmaceutical products in Russia, inpharm.com reported.The UPC which is a complex of interconnected production and infrastructure facilities is known to manufacture and sell medicines and medical equipment.The cluster has received funds worth 27.3 bn roubles (around $860m) from Russia’s economic development programme between 2010 and 2015.
Related stories
Advancing Pharmaceutical Quality Control via Technology
Improving Pharmaceutical Manufacturing Operations Success
Shilpa CDMO to Invest $50 Million in Peptide Manufacturing Expansion
World Pharma Today brings together the global pharmaceutical industry — from R&D leaders and regulatory affairs professionals to manufacturers and distribution executives — through trusted editorial, market intelligence, and digital engagement.
Our 2026 Media Pack offers integrated solutions to reach your audience:
- Magazine & Digital Editions Showcase your brand within premium pharmaceutical industry coverage read by executives and decision - makers worldwide.
- Industry Insights & Reports Align with data - driven analysis, trend reports, and regional roundups across the global pharmaceutical and life sciences value chain.
- Brand Authority & Credibility Position your company as a thought leader through expert commentary, interviews, and special features.
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Media Packs
Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!
– Access the Media Pack Now
– Book a Conference Call
– Leave Message for Us to Get Back
Latest stories
Related stories
Advancing Pharmaceutical Quality Control via Technology
Improving Pharmaceutical Manufacturing Operations Success
Shilpa CDMO to Invest $50 Million in Peptide Manufacturing Expansion
Equipment Retrofit Planning Improving Pharmaceutical Production Continuity
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Media Packs
Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!
– Access theMedia Pack Now
– Book a Conference Call
– Leave Message for Us to Get Back

















